ArticlePloS one2026
Comparative efficacy of nerve coagulation vs. cap implantation in neuroma prevention using the rat sciatic nerve model: A histological and neuroradiological insight.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPeripheral nerve injuries pose a considerable challenge in reconstructive surgery due to the risk of neuroma formation, often resulting in severe pain and significant functional impairment. Various treatment modalities, including nerve coagulation and the use of nerve caps, have been explored to manage neuroma development. In this study, we compare the efficacy of chitosan and polylactide nerve caps to standard nerve coagulation in modulating neuroma morphology and promoting organized nerve regeneration.
methodsFemale Sprague Dawley rats (n = 40) were divided into four equal groups: Sham (control), Coagulation, Polylactide Cap (Neurocap®), and Chitosan Cap. After neurotmesis of the sciatic nerve, the respective treatments were applied. The evaluation period spanned 12 weeks, with MR neurography performed at 6 and 12 weeks. Histological analyses of the harvested tissue were performed at 12 weeks. A survey among 16 plastic and nerve surgeons assessing neuroma formation and scarring was conducted.
resultsOn macroscopic evaluation, the Chitosan (C) and Polylactide (P) Cap groups displayed denser, more contained neuromas, while the Sham (S) and Coagulation (K) groups exhibited irregularly shaped neuromas with peripheral extensions. Histomorphometry showed higher axon density [ρ(C) = 15851 ± 7132 axons/mm², ρ(P) = 15657 ± 4066 axons/mm²] and thicker myelin sheaths [thm(C) = 0.808 ± 0.054 µm, thm(P) = 0.786 ± 0.045 µm] in the cap-treated groups compared to Sham [ρ(S) = 8052 ± 5080 axons/mm², thm(S) = 0.704 ± 0.060 µm; p(C/S) = 0.0193, p(P/S) = 0.0029 for axon density, p(C/S) = 0.0019, p(P/S) = 0.0046 for myelin thickness], but with no significant differences compared to the Coagulation group [ρ(K) = 14023 ± 7383 axons/mm², thm(K) = 0.745 ± 0.075 µm, p > 0.05]. Surgeon survey findings aligned with macroscopic evaluations, indicating consistency in neuroma shape classification.
conclusionChitosan and polylactide nerve caps effectively promote organized nerve regeneration and prevent disorganized neuroma formation. Nerve coagulation demonstrated comparable efficacy in certain parameters, suggesting it could remain a viable treatment option. These findings provide valuable insights for optimizing surgical approaches to peripheral nerve injuries, paving the way for more personalized and effective therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.